medanta dr naresh trehan: Live & Latest News Updates : Vimarsana.com

Antibody cocktail to treat Covid-19 now in India. What is it? Who should take the therapy?

Antibody cocktail is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms. Here is all you need to know about the therapy

Covid-19 antibody cocktail treatment, availability, cost, definition, effectiveness

Antibody cocktail is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms. Here is all you need to know about the therapy

Don't panic: AIIMS Chief answers doubts

Covid-19 is a mild disease, no need to panic: AIIMS Director Dr Randeep Guleria

Covid-19 is a mild disease, no need to panic: AIIMS Director Dr Randeep Guleria ANI | Updated: Apr 25, 2021 18:43 IST New Delhi [India], April 25 (ANI): Covid-19 is a mild disease and there is no need to panic, said AIIMS Director Dr Randeep Guleria on Sunday while addressing issues related to coronavirus with Chairman of Medanta Dr Naresh Trehan, Professor and Head of Department of Medicine AIIMS Dr Naveet Wig and Director General Health Services Dr Sunil Kumar.  “If we talk about the current situation of COVID-19, there is panic in public, Due to this panic, people are putting injections in their houses, hoarding of the Remdesivir drug and oxygen cylinder has started with this. And because of this, we are facing a shortage of supply and unnecessary panic is being created,” Guleria said.

"No Need To Panic": AIIMS Chief, Top Doctors Clear Doubts On Covid Crisis

"No Need To Panic": AIIMS Chief, Top Doctors Clear Doubts On Covid Crisis "No Need To Panic": AIIMS Chief, Top Doctors Clear Doubts On Covid Crisis According to the AIIMS Director, there are 10-15 per cent of people who may witness severe infection and may need extra medicines like Remdesivir, oxygen or plasma. India has been registering more than three lakh new COVID-19 cases on a daily basis. New Delhi: Covid-19 is a mild disease and there is no need to panic, said AIIMS Director Dr Randeep Guleria on Sunday while addressing issues related to coronavirus with Chairman of Medanta Dr Naresh Trehan, Professor and Head of Department of Medicine AIIMS Dr Naveet Wig and Director General Health Services Dr Sunil Kumar.

90 per cent of patients can recover at home if given correct medicines on time: Dr Naresh Trehan

Highlights Over 2,000 related deaths on a daily basis since the last three-four days 85 to 90 per cent of people are witnessing normal symptoms New Delhi: Covid-19 is a mild disease and there is no need to panic, said AIIMS Director Dr Randeep Guleria on Sunday (April 25) while addressing issues related to coronavirus with Chairman of Medanta Dr Naresh Trehan, Professor and Head of Department of Medicine AIIMS Dr Naveet Wig and Director General Health Services Dr Sunil Kumar. "If we talk about the current situation of COVID-19, there is panic in public, Due to this panic, people are putting injections in their houses, hoarding of the Remdesivir drug and oxygen cylinder has started with this. And because of this, we are facing a shortage of supply and unnecessary panic is being created," Guleria said.

COVID-19 is a mild disease: AIIMs director Dr Randeep Guleria addresses issues related to infection, says no need to panic

: Sunday, April 25, 2021, 6:09 PM IST 'COVID-19 is a mild disease': AIIMS director Dr Randeep Guleria addresses issues related to infection, says no need to panic Medanta chairman Dr Trehan said that 90 per cent of COVID patients can recover at home if they are provided with correct medicines on time Covid-19 is a mild disease and there is no need to panic, said AIIMS Director Dr Randeep Guleria on Sunday while addressing issues related to coronavirus with Chairman of Medanta Dr Naresh Trehan, Professor and Head of Department of Medicine AIIMS Dr Naveet Wig and Director General Health Services Dr Sunil Kumar.

90% people suffering from COVID can recover at home: Dr Naresh Trehan

COVID-19 is a mild disease, no need to panic: AIIMS Director Dr Randeep Guleria

Why India should roll out Covid-19 vaccine in the open market and ramp up its commercial export

ET Healthcare/Biotech NEWS Powered by Why India should roll out Covid-19 vaccine in the open market and ramp up its commercial export SECTIONS Why India should roll out Covid-19 vaccine in the open market and ramp up its commercial exportBy Share Synopsis India needs to innovate and play a larger role in vaccine distribution. First, it must try harder to inoculate more of its citizens as quickly as possible and simultaneously demonstrate its soft power by supplying more and more vaccines to the rest of the world. A month and a half after Covid-19 vaccination was rolled out in India, the government has allowed private hospitals to enter what was hitherto a no-go zone: vaccination on payment basis.